Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We examined trends in adherence to highly active antiretroviral therapy (HAART) and HIV RNA suppression and estimated the minimum cutoff of adherence to newer HAART formulations needed for HIV RNA suppression by regimen type. METHODS: We used Veterans Affairs pharmacy dispensing data from the Veterans Aging Cohort Study Virtual Cohort between October 2000 and September 2010 and defined adherence as the duration of time the patient had the medications available, relative to the total number of days between refills for all antiretrovirals in a year. Temporal trends in adherence and viral load suppression were examined by the patient's most frequently used HAART regimen in the year. The minimum needed adherence was defined as the level at which the odds of suppression was not significantly different than that observed with ≥ 95% adherence using repeated-measures logistic regression. RESULTS: A total of 21,865 HAART users contributed 82,217 person-years of follow-up. There was a significant increase (P(trend) < 0.001) in the proportion virally suppressed even among those with <95% adherence (2001: 38% to 2010: 84%), and the trend was similar when restricting to their first HAART regimen. For nonnucleoside reverse transcriptase inhibitor multi-pill users, the odds of suppression did not differ for 85%-89% adherence compared to those with ≥ 95% adherence [odds ratios: 0.82 (0.64-1.04)], but for protease inhibitor users, the odds of suppression significantly differed if adherence levels were <95% compared to ≥ 95% adherence. CONCLUSIONS: Although all HIV-infected persons should be instructed to achieve perfect adherence, concerns of slightly lower adherence should not hinder prescribing new HAART regimens early in HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although CASE adherence index scores above the cut-off for optimal adherence correspond to ≥ 95% adherence, many of the newer ART medications retain their effectiveness with 80% adherence [46].”
From Associations Between Patterns of Alcohol Use and Viral Load Suppression Amongst Women Living with HIV in South Africa (2021) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488 · cited 1×
“The inference of effective treatment with less than perfect adherence concurs with the literature, suggesting that on the basis of pharmacy refill data, chronically ill patients using 80% of their medications are generally categorized as being adherent to their treatment.(21) Although being 85% adherent to HAART maybe…”
MethodThe assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
Gallant, J. E., DeJesus, E., Arribas, J. R., Pozniak, A. L., Gazzard, B., Campo, R. E., Lu, B., McColl, D., Chuck, S., Enejosa, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051871 · Cited by 880
Bangsberg, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/507526 · Cited by 534
Steiner, J. F., Koepsell, T. D., Fihn, S. D., & Inui, T. S. (1988) · Medical Care · doi:10.1097/00005650-198808000-00007 · Cited by 458 · cited 1×
“2% of study population), defined as person-years with a refill frequency exceeding the scheduled dosing interval by more than 5%, because the Steiner algorithm was not validated in this subgroup.(8,11) Potential confounders of viral load suppression and adherence included sociodemographic, behavioral, disease, and tre…”
MethodNachega, J. B., Parienti, J.-J., Uthman, O. A., Gross, R., Dowdy, D. W., Sax, P. E., Gallant, J. E., Mugavero, M. J., Mills, E. J., & Giordano, T. P. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu046 · Cited by 357
Veterans Aging Cohort Study (VACS): Overview and Description
Justice, A. C., Dombrowski, E., Conigliaro, J., Fultz, S. L., Gibson, D., Madenwald, T., Goulet, J., Simberkoff, M., Butt, A. A., Rimland, D., et al. (2006) · Medical Care · doi:10.1097/01.mlr.0000223741.02074.66 · Cited by 320 · cited 2×
“The internal validity of our study is, however, boosted by this very fact because 98% of the participants do not refill their prescriptions outside the VA.24 Resistance data were not available, and hence, we do not know if PI-based regimens were used preferentially among patients with known resistance or known poor ad…”
BackgroundSelf-citationThe Implications of Therapeutic Complexity on Adherence to Cardiovascular Medications
Choudhry, N. K., Fischer, M. A., Avorn, J., Liberman, J. N., Schneeweiss, S., Pakes, J., Brennan, T. A., & Shrank, W. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.495 · Cited by 311
Development and Verification of a “Virtual” Cohort Using the National VA Health Information System
Fultz, S. L., Skanderson, M., Mole, L. A., Gandhi, N., Bryant, K., Crystal, S., & Justice, A. C. (2006) · Medical Care · doi:10.1097/01.mlr.0000223670.00890.74 · Cited by 256 · cited 1×
“Details of the Veterans Aging Cohort Study Virtual Cohort have been previously described.(7) Laboratory and clinical data and outpatient prescriptions for each subject were obtained by linking Immunology Case Registry and Pharmacy Benefits Management Registry records, respectively.”
MethodSelf-citation
Cited by
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data
Byrd, K. K., Hou, J. G., Hazen, R., Kirkham, H., Suzuki, S., Clay, P. G., Bush, T., Camp, N. M., Weidle, P. J., Delpino, A., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002142 · Cited by 285
“[17-22] However, our finding of no significant difference in the adjuste d odds of viral suppression with adherence between 80% to <85% or 85% to <90% and ≥90% is consistent with like studies.[17-23] For example, a meta-analysis of 43 studies which evalua ted dherence thresholds and virologic outcomes, found no signif…”
Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016) · Medicine · doi:10.1097/md.0000000000003361 · Cited by 277
Adherence to HIV treatment regimens: systematic literature review and meta-analysis
Altice, F., Evuarherhe, O., Shina, S., Carter, G., & Beaubrun, A. C. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s192735 · Cited by 236
“Of the 18 identified studies reporting the association between adherence and viral suppression, five (28%) had mixed outcomes or did not find an effect of adherence on virologic outcomes.(43,45,46,48,49) In two studies, adherence improved treatment outcomes with some regimens but not with others.”
BackgroundSalmasi, S., Loewen, P. S., Tandun, R., Andrade, J. G., & Vera, M. A. D. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034778 · Cited by 179
Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring
Castillo‐Mancilla, J., & Haberer, J. E. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0377-0 · Cited by 144
Metadata
- Authors
- Viswanathan, S., Justice, A. C., Alexander, G. C., Brown, T. T., Gandhi, N. R., McNicholl, I. R., Rimland, D., Rodriguez-Barradas, M. C., & Jacobson, L. P.
- Affiliations
- Michael E. DeBakey VA Medical Center (US)
- Yale University (US)
- Johns Hopkins University (US)
- Emory University (US)
- Corresponding author
- Viswanathan, Shilpa
- Alexander, G. Caleb
- Brown, Todd T.
- McNicholl, Ian R.
- Jacobson, Lisa P.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2015-08-01
- Volume
- 69
- Issue
- 4
- Pages
- 493-498
- ISSN
- 1525-4135 (ISSN-L)
- PMC
- PMC4482798
- OpenAlex
- W2323571515
- Cited by
- 98
- References
- 23
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 8 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 15 · 2016: 10 · 2015: 3
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01aa020799-09, 4u24aa022007-05)
- Agency for Healthcare Research and Quality (R01HS018372)
- U.S. Public Health Service (U01-A1069918)
- National Institute on Alcohol Abuse and Alcoholism (U24-AA022007, U01-AA020799, U01AA020790, U01AA020795, U24AA022001, U10AA013566, U24AA020794)
- National Heart, Lung, and Blood Institute (R01HL095136, R01HL107345, R01HL090342)
- National Institute of Mental Health (P30MH062294)
- National Institute on Drug Abuse (R01DA035616)
- National Cancer Institute (R01CA173754)
- National Institute of Allergy and Infectious Diseases (UM1AI035043, K24AI114444, K24AI120834, P30AI050409)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- medication adherence, HIV RNA suppression, highly active antiretroviral therapy, viral suppression, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, antiretroviral regimens
- MeSH terms
- Adult, Female, Humans, Male, Middle Aged, RNA, Viral, Sensitivity and Specificity, HIV Infections, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. https://app.cochat.ai/papers/10.1097/qai.0000000000000643
- The paper
- Viswanathan, S., Justice, A. C., Alexander, G. C., Brown, T. T., Gandhi, N. R., McNicholl, I. R., Rimland, D., Rodriguez-Barradas, M. C., & Jacobson, L. P. (2015). Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000000643
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.